cjc 1295 ipamorelin mexico CJC-1295 (NO DAC) + – Research Peptide CJC - 1295 + IPAMORELIN

Adenoidal hypertrophy and snoring/sleep apnea were also documented

Rather, the FDA has placed ipamorelin among peptides that have been restricted or excluded from compounding eligibility due to insufficient clinical evidence supporting safety and efficacy

CJC-1295: Mechanism and Duration The primary distinction between Tesamorelin and CJC-1295 lies in their duration of action and how they influence growth hormone release

Science 384 , 11961202 (2024)

CJC-1295 dosing approaches: CJC-1295 without DAC (Mod GRF 1-29): Dose: 100-200mcg per injection Frequency: 2-3x daily with meals or before bed Works synergistically with Ipamorelin/GHRP Short half-life, requires frequent dosing CJC-1295 with DAC: Dose: 1-2mg per week total Frequency: 2-3 injections weekly (or single weekly) Long-acting, elevated GH for days More convenient than without DAC Example: 5mg vial + 2ml water = 2,500mcg/ml 1mg dose (1,000mcg) = draw 0.40ml 100mcg dose (without DAC) = draw 0.04ml Most people use CJC-1295 WITH DAC for convenience

& Hanes, J